Error: Could not add to watchlist. X
+ Watchlist

Fibrocell Science Inc

FCSC:US
NASDAQ CM
0.78
USD
0.00
0.38%
As of 8:10 PM EST 1/20/2017
Open
0.78
Day Range
0.72 - 0.84
Volume
115,461
Previous Close
0.78
52Wk Range
0.52 - 3.78
1 Yr Return
-73.74%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
0.78
Day Range
0.72 - 0.84
Volume
115,461
Previous Close
0.78
52Wk Range
0.52 - 3.78
1 Yr Return
-73.74%
YTD Return
23.81%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.65
Market Cap (m USD)
34.303
Shares Outstanding (m)
43.978
Price/Sales (TTM)
85.60
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.29%
% Price Change
-0.40%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Fibrocell Science, Inc., an autologous cell and gene therapy company, focuses on treatments for skin and connective tissue diseases. The Company is developing an autologous fibroblast therapy for chronic dysphonia. Fibrocell's gene-therapy program uses gene-modified autologous fibroblasts to treat RDEB. The Company also has a gene-therapy program for linear scleroderma.
Address
405 Eagleview Blvd.
Exton, PA 19341
United States
Phone
1-484-713-6000
Show More